# Safety and efficacy of belt-type electrical stimulation for preventing disuse syndrome in elderly hemodialysis patients: a pilot study

**Authors:** Misa Miura, Shigeru Owada, Osamu Ito, Masahiro Kohzuki

PMC · DOI: 10.3389/fresc.2025.1559077 · Frontiers in Rehabilitation Sciences · 2025-07-17

## TL;DR

A pilot study explores whether belt-type electrical stimulation can safely improve physical function in elderly hemodialysis patients who struggle with exercise.

## Contribution

This study is the first to investigate the safety and potential efficacy of belt-type electrical stimulation in frail elderly hemodialysis patients.

## Key findings

- B-SES showed trends toward improved physical function without increasing inflammation.
- CT scans revealed increased thigh muscle cross-sectional area and improved intramuscular fat composition.
- Reduced intramyocellular lipids correlated with better physical performance (p < 0.05).

## Abstract

Elderly hemodialysis (HD) patients frequently experience reduced physical activity due to treatment-related immobility and fatigue, leading to accelerated functional decline. While exercise therapy is beneficial, adherence remains challenging among frail elderly patients. Belt-type electrical stimulation (B-SES) presents a potential alternative, though evidence for its safety and efficacy in this population is limited.

In this 12-week prospective intervention study, eight frail maintenance HD patients (mean age 75.5 ± 0.9 years) received B-SES therapy during HD sessions. Outcomes were assessed through physical function measures, biochemical markers, quality of life indices, and body composition analysis using multiple imaging modalities (BIA, CT, 1H-MRS).

Five participants completed the intervention, with three withdrawals unrelated to the treatment. Physical function measures showed a trend toward improvement without elevation in inflammatory markers. While BIA showed no significant changes in muscle mass, CT analysis revealed increased thigh muscle cross-sectional area, and 1H-MRS indicated improvements in intramuscular fat composition. A significant correlation emerged between reduced intramyocellular lipids and improved physical performance measures (p < 0.05).

B-SES demonstrated safety and potential efficacy in improving physical function and muscle quality among frail elderly HD patients. From a public health perspective, B-SES may serve as a feasible and accessible intervention for this population, particularly in resource-limited settings. However, further studies are needed to determine its cost-effectiveness in comparison with conventional exercise therapy.

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha) [NCBI Gene 5286] {aka CPK, OCSKD, PI3-K-C2(ALPHA), PI3-K-C2A, PI3K-C2-alpha, PI3K-C2alpha}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}
- **Diseases:** Malignant neoplasms (MESH:D009369), End-stage kidney disease (MESH:D007676), inflammatory (MESH:D007249), standing and walking disabilities (MESH:D013009), sarcopenia (MESH:D055948), muscle damage (MESH:D009133), edema (MESH:D004487), Hypertensive nephrosclerosis (MESH:D009400), cardiovascular disease (MESH:D002318), OI (OMIM:613848), Diabetic kidney disease (MESH:D003928), dementia (MESH:D003704), pneumonia (MESH:D011014), Sensory impairment (MESH:D012678), Chronic glomerulonephritis (MESH:D005921), musculoskeletal injuries (MESH:D009140), CKD (MESH:D051436), osteoporosis (MESH:D010024), disuse syndrome (MESH:D020966), fatigue (MESH:D005221), Psychiatric disorders (MESH:D001523), frailty (MESH:D000073496)
- **Chemicals:** water (MESH:D014867), SES (MESH:D012643), lipid (MESH:D008055), 1H (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310636/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12310636/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310636/full.md

---
Source: https://tomesphere.com/paper/PMC12310636